Oxford Global is delighted to announce the Stem Cell Asia Congress. The event is co-located with our Cell Therapy Asia and Cell Culture Asia Congresses bringing together 150 senior level delegates from academic and research institutions as well as from the industry. The event focuses on pioneering results stem cell engineering and manufacturing as well as stem cell-based therapeutics.
The conference agenda comprises of world-class keynote presentations delivered by internationally renowned stem cell leaders to ensure the high-level of networking and scientific platform. The conference program splits into two interactive streams:
鈥� Day 1 鈥� Stem Cell & iPSC Bioprocessing & Manufacturing
鈥� Day 2 鈥� Stem Cell Therapy & Regenerative Medicine
On day one our highly distinguished speakers will discuss stem cells and iPSC bioprocessing advancements. Presentations will cover such key areas as reprogramming and transdifferentiation updates and cell banking in order to preserve stem cell lines. Meeting the safety, quality and quantity requirements in cell manufacturing and developing 3D tissue culture technologies will also be covered.
On day two delegates will have the chance to hear pioneering research results in stem cell-based therapeutics and regenerative medicine. Presentations will provide invaluable insights into designing clinical trials for stem cell therapies, organ regeneration and successful stem cell therapy case studies to treat diabetes, brain and neurodegenerative diseases.
The conference agenda comprises of world-class keynote presentations delivered by internationally renowned stem cell leaders to ensure the high-level of networking and scientific platform. The conference program splits into two interactive streams:
鈥� Day 1 鈥� Stem Cell & iPSC Bioprocessing & Manufacturing
鈥� Day 2 鈥� Stem Cell Therapy & Regenerative Medicine
On day one our highly distinguished speakers will discuss stem cells and iPSC bioprocessing advancements. Presentations will cover such key areas as reprogramming and transdifferentiation updates and cell banking in order to preserve stem cell lines. Meeting the safety, quality and quantity requirements in cell manufacturing and developing 3D tissue culture technologies will also be covered.
On day two delegates will have the chance to hear pioneering research results in stem cell-based therapeutics and regenerative medicine. Presentations will provide invaluable insights into designing clinical trials for stem cell therapies, organ regeneration and successful stem cell therapy case studies to treat diabetes, brain and neurodegenerative diseases.
